SEC Form 4 · accession 0001127602-19-008124
Alkermes plc. · ALKS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Craig C. Hopkinson
Officer — SVP, Med Dev/Med Affairs, CMO
Period of report
Feb 21, 2019
Accepted (ET)
Feb 25, 2019 · 5:26 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001520262
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $32.57 | Feb 21, 2019 | A | 106,700 | A | Feb 21, 2020 | Feb 21, 2029 | Ordinary Shares | 106,700 | 106,700 | D |
| Restricted Stock Unit AwardF2 | $0.00 | Feb 21, 2019 | A | 27,500 | A | Feb 21, 2020 | — | Ordinary Shares | 27,500 | 27,500 | D |
Explanation of responses
- F1Shares subject to the stock option award vest in four equal annual installments commencing on 2/21/2020.
- F2Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/21/2020.